BGT226 free base

CAS No. 915020-55-2

BGT226 free base ( NVP-BGT226 )

Catalog No. M24960 CAS No. 915020-55-2

Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 104 In Stock
10MG 177 In Stock
25MG 390 In Stock
50MG 574 In Stock
100MG 803 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BGT226 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
  • Description
    Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
  • Synonyms
    NVP-BGT226
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3Kα; PI3Kβ; PI3Kγ; mTOR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    915020-55-2
  • Formula Weight
    534.5
  • Molecular Formula
    C28H25F3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(c(cnc(c1c2)ccc2-c(cc2)cnc2OC)c1N1c(cc2)cc(C(F)(F)F)c2N2CCNCC2)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Markman B , Tabernero J , Krop I , et al. Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology, 2012, 23(9):2399.
molnova catalog
related products
  • ETP-46321

    ETP-46321 is a potent, selective, orally bioavailable dual PI3K α/δ inhibitor with IC50 of 2.3/14.2 nM.

  • LX-2343

    LX-2343 is an non-ATP competitive PI3K inhibitor that negatively regulates AKT/mTOR signaling.

  • BGT226 free base

    Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.